The Application of Endoscopy in Gastrointestinal Cancers

Dear Colleagues,

Gastrointestinal malignancies represent a healthcare concern worldwide. In recent decades, several innovations in gastrointestinal endoscopy have radically changed the approach to digestive neoplasms. As a result, many preneoplastic or neoplastic lesions of the digestive tract are amenable to endoscopic resection through innovative techniques, avoiding the need for surgery. This concerns techniques such as endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), endoscopic full-thickness resection (EFTR), etc.

Moreover, endoscopy has several applications in the palliative treatment of gastrointestinal cancers unfit for curative therapies.

Finally, for cancers susceptible to population screening, such as colorectal cancer, endoscopy has a crucial role for screening and surveillance, contributing to the reduction in cancer incidence and mortality all over the world.

All these application areas place endoscopy in a leading role in the management and follow-up of gastrointestinal neoplasms.

Aim: This Special Issue aims to summarize all the main applications of endoscopy for digestive neoplasms and the evidence supporting the effectiveness and safety of main endoscopic techniques for the curative or palliative treatment of gastrointestinal cancers.

We are pleased to invite you to contribute by submitting an original research article, a meta-analysis or a narrative review. Research areas may include (but are not limited to) the following: endoscopic screening/surveillance or the endoscopic treatment of gastrointestinal cancers.

I look forward to receiving your contributions.

Prof. Dr. Marcello F. Maida
Dr. Alberto Murino
Prof. Dr. Alan Moss
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.